The Women’s Life Sciences Network was born out of a desire to foster exchanges between like-minded female professionals in the Life Sciences industry. The objectives of the Network are to provide a platform for high-level discussion of life sciences law and policy developments, facilitate and strengthen informal contact among women professionals, and mentor and promote the advancement of women in the field.
Josefine Sommer (Senior Managing Associate) and Anna Pavlou (Head of Legal, Global R&D and Regulatory – Galderma) co-founded the Women Life Sciences Network (WLSN). Donielle Mc Cutcheon (Partner), Adriana Tibbitts (Partner), and Tatjana Sachse (Counsel) also serve as WLSN Lead.
May 23, 2023 (Brussels) - The EU’s New Health Technology Assessments Regulation
September 22, 2022 (Boston) – Discussion with Lara Sullivan, President and CEO of Pyxis Oncology
November 17, 2021 (Zürich) – Discussion with Melinda Friend, General Counsel, IFPMA and Jim Stansel, Executive Vice President, General Counsel and Corporate Secretary, PhRMA
June 29, 2021 (Webinar) – Discussion with Hannah Bowden, Senior Pharmacopoeial Scientist, MHRA, Jessica Godleman, Chemist, Domino Printing UK and Jessica Mikus, Global Patent Counsel, Galderma
February 12, 2020 (Brussels) – Presentation by Isabel de la Mata, Principal Adviser for Health and Crisis Management, European Commission and Dineke Zeegers Paget, Executive Director, EUPHA
October 15, 2019 (Zurich) – Presentation by Emer Cooke, Director, Regulation of Medicines and other Health Technologies, WHO and Petra Dörr, Former Deputy Executive Director, Swissmedic, followed by a discussion with Nakisa Serry, Corporate Vice President, Associate General Counsel, Celgene International and Melinda Friend, Chief Regulatory Counsel, Colgate-Palmolive
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.
You have successfully set your edition to United States. Would you like to make this selection your default edition?
*Selecting a default edition will set a cookie.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.